Frontiers in Nutrition (May 2023)

Food groups and urologic cancers risk: a systematic review and meta-analysis of prospective studies

  • Jingyi Qi,
  • Peng An,
  • Dekui Jin,
  • Yuting Ji,
  • Sitong Wan,
  • Xu Zhang,
  • Yongting Luo,
  • Junjie Luo,
  • Chengying Zhang

DOI
https://doi.org/10.3389/fnut.2023.1154996
Journal volume & issue
Vol. 10

Abstract

Read online

BackgroundTo assess the association between 12 food groups intake and the risk of urologic cancers.MethodsWe scanned PubMed and Web of Science databases up to April 1st, 2023, and 73 publications met the inclusion criteria in the meta-analysis. We used a random effects model to estimate the summary risk ratios (RRs) and 95% confidence intervals (95% CI).ResultsIn the linear dose–response meta-analysis, an inverse association was found between each additional daily 100 g of fruits [RR: 0.89, 95%CI = (0.83, 0.97)], 100 g of vegetables [RR: 0.92, 95%CI = (0.85, 0.99)], 12 g of alcohol [RR: 0.91, 95%CI = (0.88, 0.94)] and 1 cup of coffee [RR: 0.95, 95%CI = (0.83, 0.97)] intake and the risk of renal cell carcinoma. Conversely, each additional daily 100 g of red meat intake was positively associated with renal cell carcinoma [RR: 1.41, 95%CI = (1.03, 2.10)]. Inverse associations were observed between each additional daily 50 g of egg [RR: 0.73, 95%CI = (0.62, 0.87)] and each additional daily 1 cup of tea consumption and bladder cancer risk [RR: 0.97, 95%CI = (0.94, 0.99)]. There were no significant associations for nonlinear dose–response relationships between 12 food groups and urological cancers.ConclusionOur meta-analysis strengthens the evidence that appropriate intake of specific food groups, such as fruits, vegetables, alcohol, tea, and coffee, is associated with the risk of renal cell carcinoma or bladder cancer. More studies are required to fill the knowledge gap on the links between various food groups and urologic cancers because the evidence was less credible in this meta-analysis.Systematic Review RegistrationThis study was registered on PROSPERO (CRD42022340336).

Keywords